pharma
Is the Obesity Drug Candidate from Hanmi the Best Option?
Obesity drug candidate news: Hanmi’s latest drug receives WHO name and prepares for launch.
Read MoreEVOXAC oral solution: Safe and Proven Treatment for Dry Mouth
EVOXAC oral solution is now FDA approved, providing a safe and proven option for those suffering from Sjögren’s dry mouth.
Read More
Trade Margins on Cancer Drugs: Clear Impact on Prices
Trade margins on cancer drugs are now capped at 30%, affecting pricing from November 9.
Read More
Trade Margins on Anti-Cancer Drugs: Smart Changes Ahead
Trade margins on anti-cancer drugs are now capped at 30% of the maximum retail price, impacting affordability.
Read MorePharmaceutical launches performance: Proven Success Amid Uncertainty
Pharmaceutical launches performance shows strong results despite market uncertainty. Discover key insights from Trinity’s latest report.
Read MoreWipro Acquisition Delay: A Clear Overview of the Impact
Wipro acquisition delay highlights significant changes in consulting contracts set for December 31.
Read More
Roche kidney drug: Is it the best proven treatment option?
Roche kidney drug is setting the stage for accelerated approval after its Phase 3 win. Discover its potential benefits.
Read More
FDA Approval for OMCAZIO: Is It the Best Option?
FDA approval for OMCAZIO marks a significant milestone in oncology treatment.
Read More
Sudarshan Pharma stake acquisition: Is it the best move?
Sudarshan Pharma stake acquisition is under due diligence for a 9.5% share in a US firm, raising questions about its potential impact.
Read More